Jul 13, 2016, 08:16 AM by Michael Croft

Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.

Jul 12, 2016, 15:10 PM by Michael Croft

Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.

Jul 12, 2016, 14:48 PM by Michael Croft

Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.

Jul 12, 2016, 13:07 PM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Jul 12, 2016 - Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere

Jul 11, 2016, 17:29 PM by Michael Croft

ST. LOUIS, UNITED STATES - Jul 11, 2016 - With a growing world population and a changing climate, understanding how agriculturally important plants respond to drought is crucial

Jul 11, 2016, 13:25 PM by Michael Croft

Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.

Jul 8, 2016, 08:47 AM by Michael Croft

Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.

Jul 8, 2016, 08:38 AM by Michael Croft

Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.

Jul 8, 2016, 07:37 AM by Michael Croft

OAKLAND, CA, UNITED STATES - Jul 8, 2016 - Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software

Jul 7, 2016, 11:05 AM by Michael Croft

Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.

Jul 7, 2016, 10:07 AM by Michael Croft

Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?

Jul 7, 2016, 07:34 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC - Jul 7, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc

Jul 6, 2016, 13:02 PM by Michael Croft

Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.

Jul 6, 2016, 09:43 AM by Michael Croft

PITTSBURGH, PA - Jul 6, 2016 - SAVE JON, a non-profit research accelerator that applies engineering approaches to medicine, today announced that it is relaunching as Curable

Jul 6, 2016, 05:45 AM by Michael Croft

Bio-IT World | Consumer genomics startup, Genos, is expanding its beta program and inviting Bio-IT World readers to sequence their whole exome at CLIA-certified 75x coverage for $399.

Jul 5, 2016, 10:55 AM by Michael Croft

STOCKHOLM, SWEDEN - Jul 5, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, FranceThe investment will see the introduction of a new blow fill seal high speed filling and packaging line, bringing the total number of lines from seven to eight to meet growing demand for the service

Jul 5, 2016, 09:52 AM by Michael Croft

- Jul 5, 2016 - A global life science technology firm, with headquarters in Ireland, has appointed Carlos Machado as serialization director to lead the company’s sales, operations, implementation and post project support services in the US

Jul 1, 2016, 10:35 AM by Michael Croft

Bio-IT World | Best Practices Amgen built a Real World Data platform to provide an enterprise-wide capability to better access and analyze available claims, electronic health records (EHRs), and cohort data, and address questions across the clinical and health IT development lifecycle.

Jun 29, 2016, 16:10 PM by Michael Croft

Bio-IT World  PrecisionFDA announced the results of its Truth Challenge today. Entries from Verily Life Sciences, Kinghorn Center for Clinical Genomics, and Sanofi-Genzyme won top recognition. In addition to the winners, DNAnexus, Roche, Real Time Genomics, Sentieon, Qunitiles, Macrogen, the Broad Institute, and others participated.

Jun 29, 2016, 14:45 PM by Michael Croft

Bio-IT World The Cancer Moonshot Summit today served as a platform for many announcements from both the public and private sectors on ways to advance the Moonshot’s goals.